search
cancer treatment
Trends
- 113-Year-Old Reported Cured of DIPG, Deadliest Childhood Brain CancerโA 13-Year-Old Has Been Cured of DIPG, the Deadliest Childhood Brain Cancer
A 13-year-old has reportedly become the first person cured of DIPG, an incurable and almost universally fatal childhood brain cancer. News of the case, described as a world first, has spread widely online, with readers reacting to the prospect of a breakthrough against a disease that has long defied treatment and typically claims young patients' lives within months of diagnosis.
- 2
A melanoma vaccine built on mRNA technology is in the news, with health outlets highlighting it as a promising new approach to treating the deadliest form of skin cancer. mRNA vaccines, proven at scale during the COVID-19 pandemic, are being developed to train the immune system to recognise and attack cancer cells, with several candidates now in clinical trials.
- 3Researchers link cell crowding to optimal treatment timingโTreatment resistance is one of the key challenges in cancer and antibiotic therapy. Researchers led by Dr. Jona Kayser a
Researchers led by Dr. Jona Kayser at MPZPM report that physical processes in dense cell populations strongly influence the best timing of treatment cycles, with implications for both cancer therapy and antibiotics. Treatment resistance remains one of the central challenges in medicine, and the findings suggest that timing could be adjusted based on how tightly cells pack together rather than on biology alone. The work points to new ways of scheduling therapies to delay or avoid resistance.
- 4UConn Health Launches CAR-T Cell Therapy ProgramโUConn Health Launches Cutting-Edge CAR-T Cell Therapy Program
UConn Health has announced the launch of a new CAR-T cell therapy program, bringing an advanced form of immunotherapy to its medical center in Connecticut. CAR-T treatment reengineers a patient's own immune cells to fight certain cancers, and the program is being promoted as a cutting-edge addition to the institution's clinical services.
- 5Penn Medicine and IBA Launch Proton Therapy Joint VentureโPenn Medicine, IBA Form Joint Venture to Advance Proton Therapy, Radiation Oncology
Penn Medicine and Belgian proton therapy company IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will focus on developing and expanding access to advanced cancer radiation treatments. Details on investment size, timeline and specific projects have not been announced, and the companies have not yet outlined how the venture will operate alongside existing clinical programs.
- 6Theoretical physics sheds light on tumour DNA mechanismsโTheoretical physics helps unveil the molecular mechanisms of extra-chromosomal DNA in tumours
Researchers, including Italy's National Institute for Nuclear Physics, report that theoretical physics methods have helped reveal how extra-chromosomal DNA behaves inside tumour cells. These circular DNA fragments, separate from chromosomes, are known to drive cancer growth and drug resistance. Applying physics-based modelling to their molecular mechanisms offers new insight that could inform future cancer research and treatment strategies.
- 7
New research suggests that analysing the biology of prostate cancer tumours can help doctors identify which patients are most likely to benefit from hormone therapy. The findings could support more personalised treatment decisions, allowing clinicians to target therapy at those most likely to respond rather than applying it universally. The report has drawn attention in medical news coverage.